85-4125-13 Tofacitinib Citrate (CP-690550 Citrate) 10mg CAS No:540737-29-9 290636
特徴
- CP-690550 is a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis
- Melting Point:As Reported
- Solubility:As Reported
- Method for Determining Identity:Proton NMR (DMSO-d6), 13C NMR (DMSO-d6) Spectroscopic and Mass Spectrometric Analysis
- TLC Conditions:As Reported
- Elemental Analysis:As Reported
- Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at 4ºC. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
- Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
- Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
仕様
- Size:10mg
- Grade:Highly Purified
- Molecular Formula:C22H28N6O8
- Molecular Weight Non Ab:504.49
- EU Commodity Code:38220090
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- CAS No :540737-29-9
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-4125-14
Tofacitinib Citrate (CP-690550 Citrate) 25mg
|
|
|
85-4125-15
Tofacitinib Citrate (CP-690550 Citrate) 50mg
|
|
|
85-4125-16
Tofacitinib Citrate (CP-690550 Citrate) 100mg
|
|
|
85-4125-13
Tofacitinib Citrate (CP-690550 Citrate) 10mg
|
|
|
85-4125-17
Tofacitinib Citrate (CP-690550 Citrate) 200mg
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





